HCM Hutchison MediPharma: Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan
Can HUTCHMED (China) Limited (HCM) successfully scale its developments abroad through licensing agreements? The answer lies in the creation of targeted oncology drugs and partnerships with tech giants, which generate free cash flow. The EV/EBITDA multiple dynamics for this heavy business confirm the efficiency of production capacities in the PRC, while the 0.00 indicator determines the status of the asset's fundamental value parameter.
hutch-med.com (HCM) - rincian metrik lan laporan keuangan
- rega pasar lan target rega analis:
- data kapitalisasi saham perusahaan:
- indikator nilai buku ekuitas:
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas HUTCHMED (China) Limited|HCM - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas HUTCHMED|HCM - Utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku HUTCHMED Corp|HCM - Tanggungan jangka dawa|Kewajiban jangka cendhak perusahaan HUTCHMED|Indikator likuiditas cepet hutch-med.com
- rincian asil keuangan lan kelipatan valuasi:
HCM - Bathi pungkasan|Bathi mangsa ngarep HUTCHMED (China) Limited|HCM - Rasio rega pasar marang bathi resik|Pangali Forward P/E HUTCHMED (China) Limited|HCM - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA HUTCHMED Corp|HCM - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan HUTCHMED|HCM - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan hutch-med.com|HCM - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep HUTCHMED (China) Limited
Analisis wiwitan perusahaan:HUTCHMED Ltd HCM
To find fundamental support in the capital-intensive business of HUTCHMED (HCM), which is building a global oncology therapy ecosystem, analyzing enterprise value relative to operating income is critical. By tracking changes in the EV/EBITDA multiple, an investor assesses the efficiency of profit generation before interest and taxes, allowing them to distinguish genuine asset undervaluation from a risky "value trap" during periods of market volatility.
Pesaing utama
Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Incyte Corp. INCY|Nuvation Corp (NUVB) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|DAWN - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|MNPR (monopartx.com) - Nilai perusahaan marang bathi operasional sadurunge panyusutan|INBX: Pangali EV/EBITDA|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan I-Mab Biopharma|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Fennec Pharmaceuticals Inc|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Heron Therapeutics Inc HRTX|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Nuvectis Pharma, Inc. (NVCT)|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan CHRS (Coherus BioSciences, Inc.)|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Corbus Pharmaceuticals Holdings CRBP|Cardiff Oncology Inc. (CRDF) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|BeyondSpring Pharma - Pangali EV/EBITDA|Pangali nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan BioAtla, Inc. (BCAB)|LIXT (Lixte Biotechnology) - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Citius Pharmaceuticals, Inc. (CTXR)|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan CLRB|BLRX: Nilai bisnis marang bathi operasional sadurunge panyusutan|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan CANF (Can-Fite BioPharma, Ltd.)|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan APRE|Pangali EV/EBITDA KZIA (Kazia Therapeutics Limited)|Nilai bisnis marang bathi operasional sadurunge panyusutan SLXN|NuCana Corp - Pangali EV/EBITDA|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Chimerix Inc.|Cyclacel Pharmaceuticals Inc. (CYCC) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|G1 Therapeutics - Nilai bisnis marang bathi operasional sadurunge panyusutan|KRON (Kronos Bio, Inc.) - Pangali EV/EBITDA|Pangali EV/EBITDA kintara.com|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Oncternal Therapeutics, Inc. (ONCT)|PRTG: Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan
